XML 186 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2023
Mar. 30, 2022
Cash flows from operating activities:    
Net income $ 597 $ 21,855
Adjustments to reconcile net income to cash flows provided by (used in) operating activities:    
Depreciation and amortization 3,656 3,548
Operating (gains), losses and other charges, net (1,329) 0
Losses (gains) and amortization on interest rate swaps, net 10,662 (20,253)
Amortization of deferred financing costs 159 158
Losses (gains) on investments (5) 65
Gains on early termination of debt and leases 0 24
Deferred income tax expense 133 4,436
Share-based compensation expense 3,094 4,015
Changes in assets and liabilities, excluding acquisitions and dispositions:    
Receivables 1,814 (3,567)
Inventories 2,284 (4,768)
Prepaids and other current assets 2,652 3,451
Other noncurrent assets 1,119 4,085
Operating lease assets and liabilities (246) (244)
Accounts payable (1,131) (2,405)
Other accrued liabilities (6,534) (14,964)
Other noncurrent liabilities (772) (2,500)
Net cash flows provided by (used in) operating activities 16,153 (7,064)
Cash flows from investing activities:    
Capital expenditures (1,304) (2,778)
Proceeds from sales of restaurants, real estate and other assets 1,715 108
Investment purchases (1,300) (1,200)
Collections on notes receivable 320 67
Net cash flows used in investing activities (569) (3,803)
Cash flows from financing activities:    
Revolver borrowings 35,000 13,825
Revolver payments (32,500) (12,325)
Repayments of finance leases (506) (503)
Tax withholding on share-based payments (2,846) (2,165)
Purchase of treasury stock (9,041) (12,498)
Net bank overdrafts (319) 0
Net cash flows used in financing activities (10,212) (13,666)
Increase (decrease) in cash and cash equivalents 5,372 (24,533)
Cash and cash equivalents at beginning of period 3,523 30,624
Cash and cash equivalents at end of period $ 8,895 $ 6,091